1-2 of 2
Mark D. Ewalt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance

Clinical Trials & Observations
Justin Anthony Chen, Yanli Hou, Krishna M. Roskin, Daniel A. Arber, Charles D. Bangs, Linda B. Baughn, Athena M. Cherry, Mark D. Ewalt, Andrew Z. Fire, Laure Fresard, Hutton M. Kearney, Stephen B. Montgomery, Robert S. Ohgami, Kathryn E. Pearce, Beth A. Pitel, Jason D. Merker, Jason Gotlib
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3492–3496.
https://doi.org/10.1182/bloodadvances.2020004174
Published: 2021
Includes: Supplemental data
Journal Articles

Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia

Clinical Trials & Observations
Amanda C. Winters, Jonathan A. Gutman, Enkhtsetseg Purev, Molly Nakic, Jennifer Tobin, Stephanie Chase, Jeff Kaiser, Lindsey Lyle, Chelsey Boggs, Keri Halsema, Jeffrey T. Schowinsky, Julie Rosser, Mark D. Ewalt, Bradford Siegele, Vishal Rana, Steven Schuster, Diana Abbott, Brett M. Stevens, Craig T. Jordan, Clayton Smith, Daniel A. Pollyea
Journal: Blood Advances
Blood Adv (2019) 3 (20): 2911–2919.
https://doi.org/10.1182/bloodadvances.2019000243
Published: 2019
Includes: Supplemental data